All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, report not yet due | 2005-000279-16 | Phase III Clinical Study of Allogeneic Stem Cell Transplantation with Reduced Conditioning (RICT) versus Best Standard of Care in Acute Myeloid Leukemia (AML) in First Complete Remission | 2024-10-08 | not-yet-due |
Ongoing | 2005-001008-37 | Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy | not-yet-due | |
Not reported | 2005-003867-21 | Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomis... | 2007-08-11 | due-trials |
Completed, but no date, and reported results Terminated | 2005-005544-79 | Adalimumab (Humira) as add-on therapy in the treatment of patients with severe persistent therapy resistant asthma | bad-data | |
Completed, but no date Terminated | 2006-000487-92 | A Phase II, Randomised, Double Blind, Placebo Controlled Study examining the suitability of Phenytoin Sodium Topical Gel in the treatement of Venous Ulcers | bad-data | |
Ongoing, reported early | 2008-005657-38 | Transversus Abdominis Plane Block for Analgesia in Renal Transplantation: A Randomised Controlled Trial | not-yet-due | |
Exempt Terminated | 2008-005871-92 | En fas 1 studie av effekt av Tysabri (natalizumab), en IgG4 humaniserad monoklonal antikropp specifik mot VLA-4 (integrin alfa-4), administrerad som infusion 1 gång/månad under 3 månader hos patiente... | 2008-12-31 | not-yet-due |
Completed, but no date | 2009-009039-32 | Abciximab versus Eptifibatide versus Bivalirudin during PCI in patients with acute coronary syndromes | bad-data | |
Completed, but no date | 2009-015926-13 | Treatment of Huntington´s disease with OSU 6162 - a pilot study | bad-data | |
Ongoing | 2009-016783-37 | The Effects of 18-Month Replacement with a Very Low Fixed Dose vs. Standard Dose of Growth Hormone (GH) on Insulin Sensitivity, Body Composition, Bone Mass, Lipids, Muscle Strength and Quality of Life... | not-yet-due | |
Ongoing | 2010-022065-10 | Effect of angiogenesis inhibiting therapy in patients progressing on endocrine treatment and patients with triple negative breast cancer - a translational phase II study within the Swedish Association... | not-yet-due | |
Ongoing | 2011-003418-18 | A Randomised, Double Blind, Placebo Controlled, Multi-centre, Parallel Group, Interventional Study of Mesalazine (Asacol®) Treatment in IBS and the Evaluation of Rectal Inflammatory Status using the M... | not-yet-due | |
Reported results | 2013-000564-29 | The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases | 2023-03-11 | due-trials |
Reported results | 2014-001332-11 | Aspirin for Optimising Pregnancy Outcome in Pregestational Diabetes: Pilot for The IRELAND Study (Investigating the Role of Early Low-dose Aspirin iN preexisting Diabetes) | 2016-12-06 | due-trials |
Reported results Terminated | 2014-002988-16 | The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot Study (MINT 1) | 2021-02-26 | due-trials |
Reported results | 2015-000499-89 | To measure the effects of Aspirin loading dose of 300mgs in healthy controls using AA LTA and the Dynamic Platelet Function Assay (DPFA). | 2017-06-20 | due-trials |
Ongoing | 2015-002096-14 | Examine whether treatment with methylphenidate facilitates work rehabilitation for persons with long-term pain and mental fatigue after traumatic brain injury. Undersöka om behandling med metylfeni... | not-yet-due | |
Reported results | 2015-004526-33 | A Randomised Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score | 2020-08-05 | due-trials |
Reported results | 2015-005421-40 | The use of topical Glyceryl Trinitrate (GTN) and eccentric exercises in the treatment of mid portion Achilles Tendinopathy: a randomised placebo controlled trial | 2018-12-01 | due-trials |
Reported results Terminated | 2016-000167-16 | DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma: A randomized controlled trial | 2021-01-15 | due-trials |
Reported results Terminated | 2016-001528-69 | PENICILLIN FOR THE EMERGENCY DEPARTMENT-DIRECTED OUTPATIENT TREATMENT OF CELLULITIS (PEDOCELL) STUDY: A NON-INFERIORITY ADAPTIVE RANDOMISED CONTROLLED TRIAL. | 2020-04-07 | due-trials |
Completed, report not yet due | 2016-001906-41 | A randomised control trial of intra articular injectates in knee osteoarthritis: A comparison of corticosteroid (Methylprednisolone Acetate) and NSAID (Ketorolac tromethamine) injections | 2024-11-13 | not-yet-due |
Completed, but no date | 2016-002114-50 | A multicenter phase II open label study to evaluate efficacy of concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma | bad-data | |
Exempt | 2016-002728-94 | A phase I/II, open-label study of safety, immune activation and efficacy of histamine dihydrochloride and low-dose interleukin-2 in adult tyrosine kinase inhibitor-treated patients with chronic myeloi... | not-yet-due | |
Reported results | 2016-003181-12 | Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | 2018-07-22 | due-trials |
Completed, but no date, and reported results Terminated | 2016-004471-46 | Drug level and Investigation of Novel Substances Indicated Downstream Effect in (INSIDE) glioblastoma | bad-data | |
Other | 2016-005225-37 | The ASTEROID trial - Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An open label randomized phase II trial with durvalumab following Stereotactic Body radiotherapy (SBRT) in patients ... | not-yet-due | |
Other | 2017-001499-43 | Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial) | not-yet-due | |
Other | 2017-003830-97 | Effects of an Opiod Sparing Care Pathway for Patients undergoing Obesity Surgery | not-yet-due | |
Exempt | 2017-004200-21 | A phase Ib/II randomized double-blind placebo controlled trial evaluating the effect of nivolumab for patients with in-transit melanoma metastases treated with isolated limb perfusion | not-yet-due | |
Completed, but no date, and reported results | 2017-004898-14 | See down below. Maternella serum koncentrationen av magnesium under 24 timmar efter en bolusdos (6g) av magnesiumsulfat vid hotande förtidsbörd | bad-data | |
Not reported | 2018-001021-10 | Brodalumab in a randomised, open, phase IV study evaluating clinical efficacy in psoriasis patients switching from TNF-alpha inhibitor treatment | 2020-06-18 | due-trials |
Completed, but no date Terminated | 2019-002548-26 | Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis? A pragmatic, randomised, placebo controlled trial | bad-data | |
Other | 2020-000233-41 | Labour induction in an outpatient setting - a multicenter randomized controlled trial. OPTION - OutPatienT InductiON | not-yet-due | |
Reported results | 2020-001391-15 | A randomized double-blind placebo-controlled, pilot trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness. | 2021-04-12 | due-trials |
Exempt | 2020-003188-24 | A Phase I Randomized Controlled Multicentre Trial of Isolated Hepatic Perfusion in Combination with Ipilimumab and Nivolumab in Patients with Uveal Melanoma Metastases | 2024-08-04 | not-yet-due |
Other | 2020-003444-80 | Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in addition to Minimum Inhibitory Concentration (MIC) to guide... | not-yet-due | |
Other | 2020-005176-35 | OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure (OPRA-HF) | not-yet-due | |
Completed, but no date, and reported results | 2021-000275-36 | Prevention of Glucocorticoid induced impairment of bone metabolism – A Randomized, Placebo-Controlled, Single Centre Clinical Trial | bad-data | |
Other | 2021-001806-32 | Influence of Argipressin on blood loss and inflammatory response during hepatic resection; a double blinded, randomized, placebo-controlled trial | not-yet-due | |
Reported results Terminated | 2021-004600-17 | The use of Sildenafil in Neonates with Down Syndrome to Reduce Pulmonary Vascular Resistance. | 2023-11-02 | due-trials |